Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Haim Ben-Zvi

Showing results (91-100 of 97) with videos related to

Pageof 10
Sort By:
You have reached the last page of results.This site can display upto 97 results.
Vaccines|July 29, 2023
Serologic Response and Safety after a Third Dose of the COVID-19 BNT162b2 Vaccine in Patients with Inflammatory Bowel DiseasesHadar Edelman-Klapper, Keren Masha Rabinowitz, Eran Zittan, et al.
Microbiology Spectrum|May 4, 2023
A Multi-Laboratory Evaluation of Commercial Monkeypox Virus Molecular TestsOran Erster, Itzchak Levy, Areej Kabat, et al.
Vaccine|December 14, 2021
Early effectiveness of BNT162b2 Covid-19 vaccine in preventing SARS-CoV-2 infection in healthcare personnel in six Israeli hospitals (CoVEHPI)Mark A Katz, Efrat Bron Harlev, Bibiana Chazan, et al.
Nature Medicine|June 15, 2021
Evidence for increased breakthrough rates of SARS-CoV-2 variants of concern in BNT162b2-mRNA-vaccinated individualsTalia Kustin, Noam Harel, Uriah Finkel, et al.
BMC Infectious Diseases|April 1, 2021
Excluded versus included patients in a randomized controlled trial of infections caused by carbapenem-resistant Gram-negative bacteria: relevance to external validityVered Daitch, Mical Paul, George L Daikos, et al.
Gastroenterology|October 31, 2021
Lower Serologic Response to COVID-19 mRNA Vaccine in Patients With Inflammatory Bowel Diseases Treated With Anti-TNFαHadar Edelman-Klapper, Eran Zittan, Ariella Bar-Gil Shitrit, et al.
Vaccines|July 27, 2022
Anti-TNFα Treatment Impairs Long-Term Immune Responses to COVID-19 mRNA Vaccine in Patients with Inflammatory Bowel DiseasesKeren Masha Rabinowitz, Michal Navon, Hadar Edelman-Klapper, et al.
Pageof 10

Showing results (91-100 of 97) with videos related to

Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 97 results.
Vaccines|July 29, 2023
Serologic Response and Safety after a Third Dose of the COVID-19 BNT162b2 Vaccine in Patients with Inflammatory Bowel DiseasesHadar Edelman-Klapper, Keren Masha Rabinowitz, Eran Zittan, et al.
Microbiology Spectrum|May 4, 2023
A Multi-Laboratory Evaluation of Commercial Monkeypox Virus Molecular TestsOran Erster, Itzchak Levy, Areej Kabat, et al.
Vaccine|December 14, 2021
Early effectiveness of BNT162b2 Covid-19 vaccine in preventing SARS-CoV-2 infection in healthcare personnel in six Israeli hospitals (CoVEHPI)Mark A Katz, Efrat Bron Harlev, Bibiana Chazan, et al.
Nature Medicine|June 15, 2021
Evidence for increased breakthrough rates of SARS-CoV-2 variants of concern in BNT162b2-mRNA-vaccinated individualsTalia Kustin, Noam Harel, Uriah Finkel, et al.
BMC Infectious Diseases|April 1, 2021
Excluded versus included patients in a randomized controlled trial of infections caused by carbapenem-resistant Gram-negative bacteria: relevance to external validityVered Daitch, Mical Paul, George L Daikos, et al.
Gastroenterology|October 31, 2021
Lower Serologic Response to COVID-19 mRNA Vaccine in Patients With Inflammatory Bowel Diseases Treated With Anti-TNFαHadar Edelman-Klapper, Eran Zittan, Ariella Bar-Gil Shitrit, et al.
Vaccines|July 27, 2022
Anti-TNFα Treatment Impairs Long-Term Immune Responses to COVID-19 mRNA Vaccine in Patients with Inflammatory Bowel DiseasesKeren Masha Rabinowitz, Michal Navon, Hadar Edelman-Klapper, et al.
Pageof 10